Theophylline Treatment for Pseudohypoparathyroidism

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

July 1, 2026

Study Completion Date

November 1, 2026

Conditions

PseudohypoparathyroidismAlbright Hereditary Osteodystrophy

Interventions

DRUG

Theophylline

oral theophylline

DRUG

Placebos

oral placebo

Trial Locations (1)

RECRUITING

Ashley Shoemaker, Nashville

All Listed Sponsors

collaborator

Harvard University

OTHER

lead

Vanderbilt University Medical Center

OTHER